Archives

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
Inaugural
PRNews

Inaugural "State of CX Malaysia" Research Reveals Opportunities in Customer Experience for Malaysia

KUALA LUMPUR, Malaysia, Dec. 19, 2024 /PRNewswire/ -- CX Malaysia, in collaboration with Twimbit, MDEC (Malaysia Digital Economy Corporation) and CCAM (Contact Centre Association of Malaysia), release...

  • December 19, 2024 06:55 PM AEDT
  • Cision
Smart Space Market Size Will Generate Record Revenue: $107.42 Billion by 2030
World News

Smart Space Market Size Will Generate Record Revenue: $107.42 Billion by 2030

smart space market Proliferation of advanced technologies such as IoT and AI, increase in environmental concerns WILMINGTON, NEW CASTLE, DE, UNITED STATES, December 19, 2024 /EINPresswire.com/ -- The...

Cartherics Secures Grant to Propel Ovarian Cancer Therapy
Market Updates

Cartherics Secures Grant to Propel Ovarian Cancer Therapy

Highlights,Cartherics receives a grant for advancing ovarian cancer therapy.,The funding boosts clinical manufacturing of CTH-401 treatment.,Integrated facility supports seamless transition to human trials.,Cartherics, an Australian biotechnology company,...

Significant partnership
PRNews

Significant partnership

BEIJING, Dec. 18, 2024 /PRNewswire/ -- A news report from chinadaily.com.cn: By JOSÉ MANUEL SALAZAR-XIRINACHS JIN DING/CHINA DAILY Strengthening ties with China presents a strategic opportuni...

  • December 19, 2024 06:19 PM AEDT
  • Cision
Mesoblast (ASX:MSB) Gains Momentum with FDA Approval for Ryoncil Therapy
Healthcare Stocks

Mesoblast (ASX:MSB) Gains Momentum with FDA Approval for Ryoncil Therapy

Highlights,FDA approval boosts Mesoblast (MSB) with new therapy Ryoncil.,Ryoncil marks the first approved therapy for SR-aGvHD in the US.,Mesoblast secures strong market positioning for innovative cell therapy.,Biotech company Mesoblast (ASX:MSB) witnesse...

IGF Continues to Enrich the Global Digital Dialogue
PRNews

IGF Continues to Enrich the Global Digital Dialogue

Forum serves as a global innovation and digital transformation platform RIYADH, Saudi Arabia, Dec. 19, 2024 /PRNewswire/ -- The 19th edition of the United Nations Internet Governance Forum (IGF) conti...

  • December 19, 2024 06:13 PM AEDT
  • Cision
How Trump’s U.S. Election Win is Shaping the Cryptocurrency Landscape
Cryptocurrency

How Trump’s U.S. Election Win is Shaping the Cryptocurrency Landscape

Highlights,Cryptocurrency prices surged significantly following Donald Trump’s election victory.,Market volatility heightened with speculation over regulatory shifts.,Potential policy changes may favor crypto innovation and adoption.,The cryptocurrency ma...

Golden Suisse Hosts Exclusive Event at Grand Hôtel Stockholm with Anders Borg
PRNews

Golden Suisse Hosts Exclusive Event at Grand Hôtel Stockholm with Anders Borg

ZURICH, Dec. 19, 2024 /PRNewswire/ -- Golden Suisse, a global leader in secure wealth solutions, hosted an exclusive evening at the renowned Grand Hôtel Stockholm, drawing Sweden's f...

  • December 19, 2024 06:00 PM AEDT
  • Cision
Crypto Innovations: BlockDAG Presale Leads as Arbitrum and Cardano Rise
Cryptocurrency

Crypto Innovations: BlockDAG Presale Leads as Arbitrum and Cardano Rise

Highlights,BlockDAG is achieving significant traction with record-breaking presale results.,Arbitrum (ARB) is strengthening its position in Ethereum scaling solutions.,Cardano (ADA) is expanding its DeFi ecosystem through Bitcoin liquidity integration.,Th...

Fosun International Ranks Top 5% in S&P Global's CSA among Global Peers
PRNews

Fosun International Ranks Top 5% in S&P Global's CSA among Global Peers

S&P Global Raises Fosun International's CSA Score to 70 Points, Maintaining a Leading Position in ESG Performance among Global Peers HONG KONG, Dec. 19, 2024 /PRNewswire/ -- S&P Global recentl...

  • December 19, 2024 05:46 PM AEDT
  • Cision
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.